| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
University of Nebraska Medical Center, Omaha, Nebraska
Requests for reprints: K.C. Balaji, Urological Oncology Research, Urological Surgery, 982360, University of Nebraska Medical Center, Omaha, NE 68198-2360. Phone: 402-559-9041; Fax: 402-559-6529; E-mail: kcbalaji{at}unmc.edu.
The cadherin family of transmembrane glycoproteins plays a critical role in cell-to-cell adhesion and cadherin dysregulation is strongly associated with cancer metastasis and progression. In this study, we report a novel interaction between protein kinase D1 [PKD1; formerly known as protein kinase C µ (PKCµ)] and E-cadherin. PKD1 is a serine/threonine-specific kinase known to play a role in multiple cellular processes including apoptosis, cytoskeleton remodeling, and invasion. Our study shows that PKD1 colocalizes with E-cadherin at cell junctions in LNCaP prostate cancer cells and coimmunoprecipitates with E-cadherin from lysates of LNCaP cells. In vitro kinase assays have shown that PKD1 phosphorylates E-cadherin. Inhibition of PKD1 activity by the selective inhibitor Gö6976 in LNCaP cells resulted in decreased cellular aggregation and overexpression of PKD1 in C4-2 prostate cancer cells increased cellular aggregation and decreased cellular motility. We also validated the PKD1 and E-cadherin colocalization in human prostate cancer tissue by confocal laser scanning microscopy. Our study has identified E-cadherin as a novel substrate of PKD1, and phosphorylation of E-cadherin by PKD1 is associated with increased cellular aggregation and decreased cellular motility in prostate cancer. Because both E-cadherin and PKD1 are known to be dysregulated in prostate cancer, our study identified an important protein-protein interaction influencing the signal transduction system associated with cell adhesion in prostate cancer.
Key Words: E-cadherin • PKD1 • PKCµ • prostate cancer • phosphorylation
This article has been cited by other articles:
|
|
 |
|
  J. Chen, F. Deng, S. V. Singh, and Q. J. Wang Protein Kinase D3 (PKD3) Contributes to Prostate Cancer Cell Growth and Survival Through a PKC{varepsilon}/PKD3 Pathway Downstream of Akt and ERK 1/2 Cancer Res., May 15, 2008; 68(10): 3844 - 3853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kim, H.-R. Jang, J.-H. Kim, S.-M. Noh, K.-S. Song, J.-S. Cho, H.-Y. Jeong, J. C. Norman, P. T. Caswell, G. H. Kang, et al. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion Carcinogenesis, March 1, 2008; 29(3): 629 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-B. Guo, M. Randolph, and M. Pierce Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes: INHIBITION OF EPIDERMAL GROWTH FACTOR-INDUCED DEPHOSPHORYLATION OF FOCAL ADHESION KINASE J. Biol. Chem., July 27, 2007; 282(30): 22150 - 22162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Johannessen, M. P. Delghandi, A. Rykx, M. Dragset, J. R. Vandenheede, J. Van Lint, and U. Moens Protein Kinase D Induces Transcription through Direct Phosphorylation of the cAMP-response Element-binding Protein J. Biol. Chem., May 18, 2007; 282(20): 14777 - 14787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Shen, C. Xu, R. Hu, M. R. Jain, A. Gopalkrishnan, S. Nair, M.-T. Huang, J. Y. Chan, and A.-N. T. Kong Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin Mol. Cancer Ther., January 1, 2006; 5(1): 39 - 51. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
